Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
False Claims Act: Recent enforcement trends and future outlook
What you need to know: Historic recoveries and whistleblower activity: In FY 2025, FCA settlements and judgments exceeded $6.8 billion, with whistleblowers...